LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 63 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,435 | -59.0% | 148,595 | -11.3% | 0.00% | -100.0% |
| Q2 2023 | $532,675 | +250.9% | 167,508 | +160.4% | 0.00% | – |
| Q1 2023 | $151,819 | -37.0% | 64,330 | -7.3% | 0.00% | – |
| Q4 2022 | $240,891 | -51.9% | 69,421 | +1.6% | 0.00% | -100.0% |
| Q3 2022 | $501,000 | +3.9% | 68,336 | -7.6% | 0.00% | 0.0% |
| Q2 2022 | $482,000 | +50.2% | 73,990 | +16.3% | 0.00% | – |
| Q1 2022 | $321,000 | +224.2% | 63,593 | +398.0% | 0.00% | – |
| Q4 2021 | $99,000 | -47.6% | 12,769 | 0.0% | 0.00% | – |
| Q3 2021 | $189,000 | – | 12,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |